Laboratory guidance for SARS-CoV-2 testing

We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection of neutralizing antibodies and provide practical guidance for clinical microbiology laboratories to both verify commercial serology assays and choose appropriate testing algorithms for their local populations.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 19:01 (TU)
Créé le avril 17, 2026, 19:01 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-04-29 00:00:00
open_canada_keywords {"fr": ["RMTC", "Relevé des maladies transmissibles au Canada", "COVID-19", "SRAS-CoV-2", "coronavirus", "pandémie", "Canada", "tests sérologiques", "algorithmes de sérologie"], "en": ["CCDR", "Canada Communicable Disease Report", "COVID-19", "SARS-CoV-2", "coronavirus", "pandemic", "Canada", "serological testing", "serology algorithms"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Guide pour les laboratoires pour le dépistage du SRAS-CoV-2
update_frequency as_needed